REVIEW
Accepted on 17 Jun 2025
Advances in the mechanism of small extracellular vesicles promoting the development of hepatocellular carcinoma through multi-network fusion
doi 10.3389/fimmu.2025.1558468
- 127 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Role of Extracellular Vesicles in Cancer: Implications in Immunotherapeutic Resistance
Role of Extracellular Vesicles in Cancer: Implications in Immunotherapeutic Resistance
2,413
Total downloads
11k
Total views and downloads
Articles
MINI REVIEW
Published on 12 Jun 2025
Cancer cell-derived extracellular vesicles: a potential target for overcoming tumor immunotherapy resistance and immune evasion strategies
doi 10.3389/fimmu.2025.1601266
- 420 views
REVIEW
Published on 27 May 2025
Exosomes and immune modulation: implications for neuroblastoma immunotherapy
doi 10.3389/fimmu.2025.1600062
- 1,147 views
REVIEW
Published on 22 May 2025
Role of extracellular vesicles in cancer: implications in immunotherapeutic resistance
doi 10.3389/fimmu.2025.1581635
- 806 views
CORRECTION
Published on 16 Apr 2025
Corrigendum: Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response
doi 10.3389/fimmu.2025.1595885
- 730 views
REVIEW
Published on 08 Apr 2025
Crosstalk between exosomes and tumor-associated macrophages in hepatocellular carcinoma: implication for cancer progression and therapy
doi 10.3389/fimmu.2025.1512480
- 1,769 views
ORIGINAL RESEARCH
Published on 17 Dec 2024
Activated hepatic stellate cell-derived small extracellular vesicles facilitate M2 macrophage polarization and hepatoma progression via miR-27a-3p
doi 10.3389/fimmu.2024.1489679
- 1,286 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 Oct 2024
Extracellular vesicles from human breast cancer-resistant cells promote acquired drug resistance and pro-inflammatory macrophage response
doi 10.3389/fimmu.2024.1468229
- 2,623 views
- 5 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore